β3-Adrenergic relaxation of bovine iris sphincter

FEBS Letters

Volumn 429, Issue 3, 1998, Pages 356-358

  Geyer, Orna ^b   Bar Ilan, Ayelet ^a   Nachman, Rachel ^a   Lazar, Moshe ^b   Oron, Yoram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

3 Adrenergic receptor; Bovine iris sphincter; BRL 37344; Bupranolol; Relaxation

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA ADRENERGIC RECEPTOR; BUPRANOLOL; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; ETHANOLAMINE DERIVATIVE; FORSKOLIN; ISOPRENALINE; SALBUTAMOL;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CATTLE; DRUG POTENCY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE RELAXATION; SPHINCTER PUPILLAE MUSCLE; ANIMAL; DOSE RESPONSE; DRUG EFFECT; IRIS; METABOLISM; MUSCLE RELAXATION; PHYSIOLOGY; SMOOTH MUSCLE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALBUTEROL; ANIMALS; BUPRANOLOL; CATTLE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOLAMINES; FORSKOLIN; IRIS; ISOPROTERENOL; MUSCLE RELAXATION; MUSCLE, SMOOTH; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0032537425     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00631-0     Document Type: Article

References (17)

1. Zaagsma J., Nahorski S.R. Trends Pharmacol. Sci. 11:1990;3-7.
2. Emorine L.J., Marullo S., Briend-Sutren M.M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A.D. Science. 245:1989;1118-1121.
3. Granneman J.G., Lahners K.N., Chaudhry A. Mol. Pharmacol. 40:1991;895-899.
4. Muzzin P., Revelli J.P., Kuhne F., Gocane J.D., McCombie W.R., Venter J.C., Giancobino J.P., Fraser C.M. J. Biol. Chem. 266:1991;24053-24058.
5. Nahmias C., Blin N., Elalouf J.M., Matell M.G., Strosberg A.D., Emorine L.J. EMBO J. 10:1991;3721-3727.
6. Blin N., Nahmias C., Drumare M.F., Strosberg A.D. Br. J. Pharmacol. 112:1994;911-919.
7. Lelias J.M., Kaghad M., Rodriguez M., Chalon P., Bonnik J., Dupre I., Delpech B., Bensaid M., Lefur F.G., Ferra P., Caput D. FEBS Lett. 324:1993;127-130.
8. Krief S., Lonnqvist F., Raimbault S., Baude B., van Spronsen A., Arner P., Strosberg A.D., Ricquier D.A., Emorine L.J. J. Clin. Invest. 91:1993;344-349.
9. Strosberg A.D. Annu. Rev. Pharmacol. Toxicol. 37:1997;421-450.
10. Spessert R., Lyes E., Vollrath L. J. Neurochem. 61:1993;138-143.
11. Graves J., Poston L. Br. J. Pharmacol. 108:1993;631-637.
12. Martinez-Cuesta M.A., Moreno L., Pique J.M., Bosch J., Rodrigo J., Esplugues J.V. Gastroenterology. 111:1996;727-735.
13. Patil P.N. J. Pharmacol. Exp. Ther. 166:1968;299-307.
14. Patil P.N., Weber P.A. J. Ocul. Pharmacol. 7:1991;297-300.
15. Manara L., Badone D., Baroni M., Boccardi G., Cecchi R., Croci T., Giudice A., Guzzi U., Landi M., Le Fur G. Br. J. Pharmacol. 117:1996;435-442.
16. Galitzky J., Reverte M., Portillo M., Caprene C., Lafontan M., Berlan M. Am. J. Physiol. 264:1993;E403-E412.
17. Langin D., Maria P., Portillo M.P., Saulnier-Blache J.S., Lafontan M. Eur. J. Pharmacol. 199:1991;291-301.